Valuation Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:37 2025-11-14 EST			5-day change	1st Jan Change
104.42 ^CHF	-1.25%		+2.37%	+17.72%

11-14	Swiss official says pharma sector to make up large part of US investment	RE
11-13	European Markets Set to Open Higher After End of U.S. Shutdown	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	215,322	196,458	194,448	207,167	195,514	252,575	-	-
Change	-	-8.76%	-1.02%	6.54%	-5.62%	29.19%	-	-
Enterprise Value (EV) ¹	239,822	204,649	203,482	219,178	213,458	272,889	275,249	270,983
Change	-	-14.67%	-0.57%	7.71%	-2.61%	27.84%	0.86%	-1.55%
P/E ratio	26.7x	8.2x	28.3x	14.1x	16.5x	18.2x	17.7x	16.1x
PBR	3.78x	2.9x	3.23x	4.41x	4.52x	5.85x	5.39x	4.9x
PEG	-	0x	-0.4x	0x	-1x	0.8x	6.26x	1.6x
Capitalization / Revenue	4.43x	3.81x	3.85x	4.56x	3.89x	4.56x	4.46x	4.3x
EV / Revenue	4.93x	3.96x	4.03x	4.82x	4.24x	4.93x	4.86x	4.61x
EV / EBITDA	14.2x	11.2x	10.9x	12.2x	10.2x	11.7x	11.5x	10.7x
EV / EBIT	15.6x	12.3x	12.2x	13.4x	10.9x	12.5x	12.6x	11.7x
EV / FCF	20.5x	15.4x	17x	16.6x	13.1x	20.1x	17.8x	16.5x
FCF Yield	4.87%	6.49%	5.87%	6.01%	7.61%	4.98%	5.61%	6.07%
Dividend per Share ²	3.375	3.36	3.5	3.823	3.856	4.046	4.229	4.319
Rate of return	3.57%	3.83%	3.87%	3.79%	3.94%	3.07%	3.21%	3.28%
EPS ²	3.55	10.71	3.19	7.15	5.92	7.22	7.424	8.175
Distribution rate	95.1%	31.4%	110%	53.5%	65.1%	56%	57%	52.8%
Net sales ¹	48,659	51,626	50,545	45,440	50,317	55,351	56,672	58,798
EBITDA ¹	16,845	18,246	18,613	17,937	21,006	23,414	23,878	25,391
EBIT ¹	15,416	16,588	16,665	16,372	19,494	21,873	21,819	23,151
Net income ¹	8,072	24,021	6,955	14,854	11,939	14,290	14,481	15,557
Net Debt ¹	24,500	8,191	9,034	12,011	17,944	20,313	22,674	18,408
Reference price ²	94.67	87.82	90.40	100.79	97.79	131.63	131.63	131.63
Nbr of stocks (in thousands)	2,274,506	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	-	-
Announcement Date	1/26/21	2/2/22	2/1/23	1/31/24	1/31/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVARTIS AG	18.49x	4.99x	11.81x	3.03%	256B
ELI LILLY AND COMPANY	45.02x	14.83x	33.08x	0.58%	916B
JOHNSON & JOHNSON	17.66x	5.24x	14.49x	2.65%	470B
ABBVIE INC.	56.14x	7.66x	18.14x	2.81%	411B
ROCHE HOLDING AG	17.22x	4.25x	10.61x	3.41%	314B
ASTRAZENECA PLC	26.7x	5.07x	15.03x	1.81%	276B
MERCK & CO., INC.	11.83x	3.93x	8.5x	3.48%	231B
NOVO NORDISK A/S	13.74x	4.92x	10.22x	3.63%	221B
AMGEN INC.	26.32x	6.21x	10.7x	2.84%	181B
GILEAD SCIENCES, INC.	18.19x	5.76x	10.52x	2.64%	155B
Average	25.13x	6.28x	14.31x	2.69%	343.06B
Weighted average by Cap.	30.15x	7.93x	18.32x	2.27%